Tumours of Haematopoietic and Lymphoid Tissues: Difference between revisions
No edit summary |
No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Myeloproliferative Neoplasms (MPN)== | ==Myeloproliferative Neoplasms (MPN) ([[Myeloproliferative Neoplasms (MPN)|Overview Page Link]])== | ||
*[[Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive]] | *[[Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive]] | ||
| Line 9: | Line 9: | ||
*[[Myeloproliferative Neoplasm (MPN), Unclassifiable]] | *[[Myeloproliferative Neoplasm (MPN), Unclassifiable]] | ||
==Mastocytosis== | ==Mastocytosis ([[Mastocytosis|Overview Page Link]])== | ||
*[[Cutaneous Mastocytosis]] | *[[Cutaneous Mastocytosis]] | ||
| Line 15: | Line 15: | ||
*[[Mast Cell Sarcoma]] | *[[Mast Cell Sarcoma]] | ||
==Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2== | ==Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 ([[Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2|Overview Page Link]])== | ||
*[[Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement]] | *[[Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement]] | ||
| Line 22: | Line 22: | ||
*[[Myeloid/Lymphoid Neoplasms with PCM1-JAK2]] | *[[Myeloid/Lymphoid Neoplasms with PCM1-JAK2]] | ||
==Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)== | ==Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) ([[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)|Overview Page Link]])== | ||
*[[Chronic Myelomonocytic Leukemia (CMML)]] | *[[Chronic Myelomonocytic Leukemia (CMML)]] | ||
| Line 30: | Line 30: | ||
*[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable|MDS/MPN, Unclassifiable]] | *[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable|MDS/MPN, Unclassifiable]] | ||
==Myelodysplastic Syndromes (MDS)== | ==Myelodysplastic Syndromes (MDS) ([[Myelodysplastic Syndromes (MDS)|Overview Page Link]])== | ||
*[[Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia|MDS with Single Lineage Dysplasia]] | *[[Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia|MDS with Single Lineage Dysplasia]] | ||
| Line 89: | Line 89: | ||
- [[Myeloid Leukemia Associated with Down Syndrome]] | - [[Myeloid Leukemia Associated with Down Syndrome]] | ||
==Blastic Plasmacytoid Dendritic Cell Neoplasm== | ==Blastic Plasmacytoid Dendritic Cell Neoplasm ([[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== | ||
*[[Blastic Plasmacytoid Dendritic Cell Neoplasm]] | *[[Blastic Plasmacytoid Dendritic Cell Neoplasm]] | ||
==Acute Leukemias of Ambiguous Lineage (MPAL)== | ==Acute Leukemias of Ambiguous Lineage (MPAL) ([[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== | ||
*[[Acute Leukemias of Ambiguous Lineage]] | *[[Acute Leukemias of Ambiguous Lineage]] | ||
| Line 105: | Line 105: | ||
- [[Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]] | - [[Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]] | ||
==Precursor Lymphoid Neoplasms (B-ALL, T-ALL)== | ==Precursor Lymphoid Neoplasms (B-ALL, T-ALL) ([[Precursor Lymphoid Neoplasms|Overview Page Link]])== | ||
*[[B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities|B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities]] | *[[B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities|B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities]] | ||
| Line 125: | Line 125: | ||
- [[NK-Lymphoblastic Leukemia/Lymphoma]] | - [[NK-Lymphoblastic Leukemia/Lymphoma]] | ||
==Mature B-Cell Neoplasms (CLL, Plasma Cell Neoplasms, Non-Hodgkin B-cell Lymphomas)== | ==Mature B-Cell Neoplasms (CLL, Plasma Cell Neoplasms, Non-Hodgkin B-cell Lymphomas) ([[Mature B-Cell Neoplasms|Overview Page Link]])== | ||
*[[Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma]] | *[[Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma]] | ||
| Line 235: | Line 235: | ||
*[[B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma]] | *[[B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma]] | ||
==Mature T- and NK-cell Neoplasms== | ==Mature T- and NK-cell Neoplasms ([[Mature T- and NK-cell Neoplasms|Overview Page Link]])== | ||
*[[T-cell Prolymphocytic Leukemia]] | *[[T-cell Prolymphocytic Leukemia]] | ||
| Line 297: | Line 297: | ||
*[[Breast Implant-Associated Anaplastic Large Cell Lymphoma]] | *[[Breast Implant-Associated Anaplastic Large Cell Lymphoma]] | ||
==Hodgkin Lymphomas== | ==Hodgkin Lymphomas ([[Hodgkin Lymphomas|Overview Page Link]])== | ||
*[[Nodular Lymphocyte Predominant Hodgkin Lymphoma]] | *[[Nodular Lymphocyte Predominant Hodgkin Lymphoma]] | ||
| Line 308: | Line 308: | ||
- [[Lymphocyte-Depleted Classic Hodgkin Lymphoma]] | - [[Lymphocyte-Depleted Classic Hodgkin Lymphoma]] | ||
==Immunodeficiency-Associated Lymphoproliferative Disorders== | ==Immunodeficiency-Associated Lymphoproliferative Disorders ([[Immunodeficiency-Associated Lymphoproliferative Disorders|Overview Page Link]])== | ||
*[[Lymphomas Associated with HIV Infection]] | *[[Lymphomas Associated with HIV Infection]] | ||
| Line 323: | Line 323: | ||
*[[Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders]] | *[[Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders]] | ||
==Histiocytic and Dendritic Cell Neoplasms== | ==Histiocytic and Dendritic Cell Neoplasms ([[Histiocytic and Dendritic Cell Neoplasms|Overview Page Link]])== | ||
*[[Histiocytic Sarcoma]] | *[[Histiocytic Sarcoma]] | ||